<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://neomed.omeka.net/items/browse?tags=Triquinylamine&amp;output=omeka-xml" accessDate="2026-03-08T16:00:15-04:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>40</perPage>
      <totalResults>1</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="2978" public="1" featured="1">
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>URL Address</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="36757">
              <text>&lt;a href="http://doi.org/10.1002/ardp.201500293" target="_blank" rel="noreferrer noopener"&gt;http://doi.org/10.1002/ardp.201500293&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="55">
          <name>Pages</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="36759">
              <text>252–267</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="56">
          <name>Issue</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="36760">
              <text>4</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="57">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="36761">
              <text>349</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="36749">
                <text>Synthesis and Biological Evaluation of Pentacycloundecylamines and Triquinylamines as Voltage-Gated Calcium Channel Blockers.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="36750">
                <text>Archiv der Pharmazie</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="36751">
                <text>2016</text>
              </elementText>
              <elementText elementTextId="36752">
                <text>2016-04</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="36753">
                <text>Alicyclic/chemical synthesis/*chemistry/pharmacology; Amines/chemical synthesis/*chemistry/pharmacology; Animals; Apoptosis/drug effects; Calcium Channel Blockers/chemical synthesis/*chemistry/pharmacology; Calcium Channels; Calcium/*metabolism; Cell Survival/drug effects; Hydrocarbons; Hydrogen Peroxide/pharmacology; L-Lactate Dehydrogenase/metabolism; L-type calcium channel (LTCC) blockers; L-Type/*metabolism; Multifunctional drugs; Neurodegeneration; PC12 Cells; Pentacycloundecylamine; Quinones/chemical synthesis/*chemistry/pharmacology; Rats; Structure-Activity Relationship; Triquinylamine</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="36754">
                <text>Young Lois-May; Geldenhuys Werner J; Domingo Olwen C; Malan Sarel F; Van der Schyf Cornelis J</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="36755">
                <text>Preclinical studies for neurodegenerative diseases have shown a multi-targeted approach to be successful in the treatment of these complex disorders with several pathoetiological pathways. Polycyclic compounds, such as NGP1-01 (7a), have demonstrated the ability to target multiple mechanisms of the complex etiology and are referred to as multifunctional compounds. These compounds have served as scaffolds with the ability to attenuate Ca(2+) overload and excitotoxicity through several pathways. In this study, our focus was on mitigating Ca(2+) overload through the L-type calcium channels (LTCC). Here, we report the synthesis and biological evaluation of several novel polycyclic compounds. We determined the IC50 values for both the pentacycloundecylamines and the triquinylamines by means of a high-throughput fluorescence calcium flux assay utilizing Fura-2/AM. The potential of these compounds to offer protection against hydrogen peroxide-induced cell death was also evaluated. Overall,</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="36756">
                <text>&lt;a href="http://doi.org/10.1002/ardp.201500293" target="_blank" rel="noreferrer noopener"&gt;10.1002/ardp.201500293&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="36758">
                <text>Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="183">
        <name>2016</name>
      </tag>
      <tag tagId="21448">
        <name>Alicyclic/chemical synthesis/*chemistry/pharmacology</name>
      </tag>
      <tag tagId="21449">
        <name>Amines/chemical synthesis/*chemistry/pharmacology</name>
      </tag>
      <tag tagId="123">
        <name>Animals</name>
      </tag>
      <tag tagId="1065">
        <name>Apoptosis/drug effects</name>
      </tag>
      <tag tagId="1062">
        <name>Archiv der Pharmazie</name>
      </tag>
      <tag tagId="21450">
        <name>Calcium Channel Blockers/chemical synthesis/*chemistry/pharmacology</name>
      </tag>
      <tag tagId="1067">
        <name>Calcium Channels</name>
      </tag>
      <tag tagId="21451">
        <name>Calcium/*metabolism</name>
      </tag>
      <tag tagId="1069">
        <name>Cell Survival/drug effects</name>
      </tag>
      <tag tagId="1084">
        <name>Domingo Olwen C</name>
      </tag>
      <tag tagId="1083">
        <name>Geldenhuys Werner J</name>
      </tag>
      <tag tagId="1070">
        <name>Hydrocarbons</name>
      </tag>
      <tag tagId="1071">
        <name>Hydrogen Peroxide/pharmacology</name>
      </tag>
      <tag tagId="1072">
        <name>L-Lactate Dehydrogenase/metabolism</name>
      </tag>
      <tag tagId="1073">
        <name>L-type calcium channel (LTCC) blockers</name>
      </tag>
      <tag tagId="21452">
        <name>L-Type/*metabolism</name>
      </tag>
      <tag tagId="1085">
        <name>Malan Sarel F</name>
      </tag>
      <tag tagId="1075">
        <name>Multifunctional drugs</name>
      </tag>
      <tag tagId="1076">
        <name>Neurodegeneration</name>
      </tag>
      <tag tagId="1077">
        <name>PC12 Cells</name>
      </tag>
      <tag tagId="1078">
        <name>Pentacycloundecylamine</name>
      </tag>
      <tag tagId="21453">
        <name>Quinones/chemical synthesis/*chemistry/pharmacology</name>
      </tag>
      <tag tagId="469">
        <name>Rats</name>
      </tag>
      <tag tagId="1080">
        <name>Structure-Activity Relationship</name>
      </tag>
      <tag tagId="1081">
        <name>Triquinylamine</name>
      </tag>
      <tag tagId="21454">
        <name>Van der Schyf Cornelis J</name>
      </tag>
      <tag tagId="1082">
        <name>Young Lois-May</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
